Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About CISS Interactive Breakdown Better Bets vs. CISS Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

C3is (CISS)

Market Price (10/31/2025): $2.12 | Market Cap: $1.7 Mil
Sector: Industrials | Industry: Marine Transportation

C3is (CISS)

Market Price (10/31/2025): $2.12
Market Cap: $1.7 Mil
Sector: Industrials
Industry: Marine Transportation

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 466%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 462%, FCF Yield is 380%		 Weak multi-year price returns
2Y Excs Rtn is -165%		 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -21%, Rev Chg QQuarterly Revenue Change % is -0.8%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -132%		  Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 336%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 17%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%		  High stock price volatility
Vol 12M is 588%
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 466%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 462%, FCF Yield is 380%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -132%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 17%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%
3 Weak multi-year price returns
2Y Excs Rtn is -165%
4 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -21%, Rev Chg QQuarterly Revenue Change % is -0.8%
5 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 336%
6 High stock price volatility
Vol 12M is 588%

Market Valuation & Key Metrics

CISSS&P 500
REVENUE GROWTHPOOR
Rev LTM ($ Bil)0.0
Rev Chg Q-0.8%6.4%
Rev Chg LTM-20.9%5.4%
Rev Chg 3Y Avg143.3%5.3%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)0.0
CFO LTM ($ Bil)0.0
Net Inc LTM ($ Bil)0.0
Op Mgn LTM10.5%18.7%
CFO/Rev LTM17.5%20.4%
Net Inc Mgn21.4%12.8%
VALUATIONVERY LOW
P/S0.03.2
P/CFO0.315.5
P/FCF0.320.6
P/E0.223.6
STABILITYGOOD
Debt/Equity0.040.21
Cash/Assets0.030.07

CISS Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The -44.0% change in CISS stock from 5/1/2025 to 10/30/2025 was primarily driven by a -70.1% change in the company's Shares Outstanding (Mil).

501202510302025Change
Stock Price ($)3.822.14-43.98%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)40.6436.42-10.36%
P/S Multiple0.040.056.34%
Shares Outstanding (Mil)0.460.78-70.14%
Cumulative Contribution-71.54%

LTM = Last Twelve Months as of date shown
The -87.8% change in CISS stock from 10/30/2024 to 10/30/2025 was primarily driven by a -97.4% change in the company's P/E Multiple.

1030202410302025Change
Stock Price ($)17.552.14-87.81%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)46.0236.42-20.86%
Net Income Margin (%)2.03%21.44%957.21%
P/E Multiple8.140.21-97.36%
Shares Outstanding (Mil)0.430.78-80.85%
Cumulative Contribution-95.78%

LTM = Last Twelve Months as of date shown
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
CISS Return-----99%-75%-100%
Peers Return0%53%7%10%117%-4%275%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
CISS Win Rate---33%17%11% 
Peers Win Rate28%37%42%43%42%59% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
CISS Max Drawdown-----99%-94% 
Peers Max Drawdown-34%-1%-10%-17%-18%-31% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: GSL, GNK, PANL, CMDB, HTCO.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

CISS has limited trading history. Below is the Industrials sector ETF (XLI) in its place.

Unique KeyEventXLIS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-22.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven29.2%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven273 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-42.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven74.8%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven232 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-24.6%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven32.6%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven312 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-63.3%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven172.8%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1463 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -22.6% during the 2022 Inflation Shock from a high on 1/4/2022. A -22.6% loss requires a 29.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About C3is (CISS)

Better Bets than C3is (CISS)

 CISSBetter Performance than CISS
MetricValueIndustry (Marine Transportation)
Rev Chg LTM-20.9%KEX (2.4%), HAFN (-20.7%), MATX (8.8%), SBLK (3.0%), BWLP (1.3%)
Op Mgn LTM10.5%KEX (14.3%), HAFN (18.7%), MATX (16.6%), SBLK (15.0%), ZIM (28.8%)
CFO/Rev LTM17.5%KEX (17.8%), HAFN (34.2%), MATX (17.8%), SBLK (28.0%), ZIM (46.0%)
FCF/Rev LTM17.5%HAFN (30.4%), SBLK (25.0%), ZIM (43.4%), DAC (18.1%), ECO (25.2%)
Total Yield466.3%
 CISSBetter Performance than CISS
MetricValueAll Other Sectors
Rev Chg LTM-20.9%NVDA (71.6%), AAPL (6.0%), MSFT (15.6%), GOOGL (13.4%), AMZN (10.9%)
Op Mgn LTM10.5%NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AMZN (11.4%)
CFO/Rev LTM17.5%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM17.5%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AVGO (41.6%)
Total Yield466.3%TM (2018.7%), HMC (2171.7%), SLB (9751.7%), NXTT (657.3%), WIMI (610.1%)
 Best Bets In Industrials Sector
 CISSGATX VRSK ADT CPRT NDSN TDG PCTY FTV VRRM CSL
What You Pay           
P/E0.217.832.911.726.528.839.336.828.173.311.4
P/EBIT0.28.522.55.624.219.519.127.813.721.712.6
What You Get           
Rev Chg Q-0.8%11.3%5.9%6.8%5.2%12.1%9.3%12.2%2.3%16.1%-0.1%
Rev Chg LTM-20.9%11.7%7.3%6.6%9.7%4.5%12.8%7.0%27.9%8.5%4.4%
Rev Chg 3Y Avg�9.8%13.4%2.6%9.9%3.6%18.2%22.7%9.4%9.1%5.2%
FCF/Rev 3Y Avg-18.4%38.6%33.2%24.1%23.7%21.5%20.8%20.5%20.1%19.0%18.3%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 16%, alpha of 4.2%, and sharpe of 0.76

Latest Trefis Analyses

Trade Ideas

Select past ideas related to CISS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
FCN_9302025_Dip_Buyer_ValueBuy09302025FCNFTI ConsultingDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		4.4%4.4%-6.2%
ODFL_9122025_Monopoly_xInd_xCD_Getting_Cheaper09122025ODFLOld Dominion Freight LineMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.0%-6.0%-7.3%
EFX_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025EFXEquifaxMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-12.9%-12.9%-12.9%
UHAL_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025UHALU-HaulMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.2%-7.2%-7.2%
BWXT_8312025_Quality_Momentum_RoomToRun_10%08312025BWXTBWX TechnologiesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		31.9%31.9%-1.2%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
FCN_9302025_Dip_Buyer_ValueBuy09302025FCNFTI ConsultingDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		4.4%4.4%-6.2%
ODFL_9122025_Monopoly_xInd_xCD_Getting_Cheaper09122025ODFLOld Dominion Freight LineMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-6.0%-6.0%-7.3%
EFX_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025EFXEquifaxMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-12.9%-12.9%-12.9%
UHAL_8312025_Monopoly_xInd_xCD_Getting_Cheaper08312025UHALU-HaulMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.2%-7.2%-7.2%
BWXT_8312025_Quality_Momentum_RoomToRun_10%08312025BWXTBWX TechnologiesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		31.9%31.9%-1.2%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for C3is

Financials

CISSGSLGNKPANLCMDBHTCOMedian
NameC3is Global S.Genco Sh.Pangaea .Costamar.High-Tre. 
Mkt Price2.1430.6616.724.8812.7910.3011.54
Mkt Cap0.01.10.70.3--0.5
Rev LTM36730351580--465
Op Inc LTM43812236--29
FCF LTM614112-4--9
FCF 3Y Avg42435126--39
CFO LTM64467458--66
CFO 3Y Avg1240810665--85

Growth & Margins

CISSGSLGNKPANLCMDBHTCOMedian
NameC3is Global S.Genco Sh.Pangaea .Costamar.High-Tre. 
Rev Chg LTM-20.9%4.0%-17.2%15.1%---6.6%
Rev Chg 3Y Avg-11.2%-16.5%-9.1%---9.1%
Rev Chg Q-0.8%8.7%-24.4%19.2%--3.9%
QoQ Delta Rev Chg LTM-0.2%2.1%-6.9%4.5%--0.9%
Op Mgn LTM10.5%52.2%6.3%6.3%--8.4%
Op Mgn 3Y Avg24.8%53.0%13.8%9.3%--19.3%
QoQ Delta Op Mgn LTM-6.4%-0.2%-5.5%-1.0%---3.2%
CFO/Rev LTM17.5%61.1%21.1%10.0%--19.3%
CFO/Rev 3Y Avg33.7%59.1%25.6%12.0%--29.7%
FCF/Rev LTM17.5%19.4%3.5%-0.7%--10.5%
FCF/Rev 3Y Avg-18.4%35.5%11.7%5.1%--8.4%

Valuation

CISSGSLGNKPANLCMDBHTCOMedian
NameC3is Global S.Genco Sh.Pangaea .Costamar.High-Tre. 
Mkt Cap0.01.10.70.3--0.5
P/S0.01.52.10.5--1.0
P/EBIT0.22.527.79.1--5.8
P/E0.22.847.035.4--19.1
P/CFO0.32.49.85.4--3.9
Total Yield466.3%42.1%9.2%9.0%--25.7%
Dividend Yield0.0%6.1%7.1%6.2%--6.1%
FCF Yield 3Y Avg-228.5%27.8%8.1%7.9%--8.0%
D/E0.00.70.10.4--0.3
Net D/E-1.30.30.10.2--0.2

Returns

CISSGSLGNKPANLCMDBHTCOMedian
NameC3is Global S.Genco Sh.Pangaea .Costamar.High-Tre. 
1M Rtn-0.2%-0.1%-6.1%-3.9%-11.0%37.5%-2.1%
3M Rtn-33.1%9.4%5.9%1.2%42.1%27.9%7.7%
6M Rtn-44.0%47.9%27.7%21.2%--67.0%21.2%
12M Rtn-87.8%42.7%14.0%-18.7%--60.0%-18.7%
3Y Rtn-125.7%57.4%21.0%--57.4%
1M Excs Rtn-3.3%-1.7%-7.9%-4.8%-11.9%35.7%-4.0%
3M Excs Rtn-41.9%1.1%-2.7%-2.0%29.7%3,010.9%-0.5%
6M Excs Rtn-65.7%26.2%6.0%-0.5%--88.8%-0.5%
12M Excs Rtn-105.3%22.6%-3.1%-34.0%--76.6%-34.0%
3Y Excs Rtn-34.8%-27.8%-62.8%---27.8%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q22022Q1
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/20236/30/20223/31/2022
Filing Date9/2/20255/16/20254/28/202511/19/20248/23/20245/28/20244/30/202411/19/20249/8/20237/3/20231/25/20237/3/2023
Key Financials Quarterly            
Total Revenue11989111312102351
Ebitda-41027-96850130
Operating Income11103564-012-0
Net Income-5805-12463-012-0
EPS-8.7814.899.4210.35-27.6116.611219.89645.00-181.05354.241095.58-64.97
Key Financials TTM            
Total Revenue TTM36374145463727201112--
Ebitda TTM15106121019151055--
Operating Income TTM461015191510734--
Net Income TTM81-331129634--
Growth Rates Quarterly            
Total Revenue Growth-0.8%-32.2%-37.0%-8.3%535.7%305.9%141.5%651.2%-13.6%---
EBITDA Growth60.5%66.7%-72.7%33.9%-3115.3%316.5%183.8%8788.6%-75.3%---
Operating Income Growth-69.0%-76.0%-81.6%-90.0%1036.1%584.0%156.1%4490.8%-133.2%---
Net Income Growth54.7%109.1%-97.4%52.3%-3136.8%404.0%139.8%2517.4%-133.1%---
Margins Quarterly            
EBITDA Margin-34.1%113.9%27.1%77.1%-85.6%46.3%62.6%52.8%18.0%45.1%53.3%4.5%
Operating Income Margin9.9%14.2%14.4%4.3%31.5%40.2%49.5%39.1%-21.4%23.8%46.7%-6.7%
Net Income Margin-49.6%91.3%1.9%54.8%-108.6%29.6%45.3%33.0%-21.3%23.8%45.6%-10.2%
Cash & Debt            
Total Cash21613846359-552-
Total Debt000000000070
Net Debt / (Cash)-2-16-13-8-45-35-9--5-55-
Cash Flows Quarterly            
FCF from Operations-135-17150411-12
Cash Flows TTM            
FCF from Operations TTM613252025206532--
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC5.9%8.8%7.6%2.6%57.5%93.0%63.9%--3.9%7.7%35.5%-
Return on Invested Capital (ROIC) TTM            
ROIC TTM5.3%11.0%17.2%24.5%78.4%67.0%27.3%-7.1%10.6%--

Price Behavior

CISS Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta-2.10-0.58-0.60-12.30-8.000.12
Up Beta-14.33-1.38-1.471.100.88-0.49
Down Beta10.921.241.19-39.05-27.662.17
Up Capture-402%-187%-148%-66%-37%-5%
Bmk +ve Days13233574144420
Stock +ve Days6162554105231
Down Capture226%135%89%-1764%114%110%
Bmk -ve Days8192952107330
Stock -ve Days13233265135312

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity49,544
Short Interest: % Change Since 9302025-81.6%
Average Daily Volume8,833,250
Days-to-Cover Short Interest1
Basic Shares Quantity782,631
Short % of Basic Shares6.3%

Returns Analyses

SEC Filings

Expand for More

Report DateFiling DateFiling
630202590220256-K 6/30/2025
331202551620256-K 3/31/2025
12312024428202520-F 12/31/2024
9302024111920246-K 9/30/2024
630202482320246-K 6/30/2024
331202452820246-K 3/31/2024
12312023430202420-F 12/31/2023
630202390820236-K 6/30/2023
33120237032023424B4 3/31/2023
123120226122023424B1 12/31/2022
63020221252023DRS/A 6/30/2022

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.